Suppr超能文献

比较乳腺癌细胞系和原发性乳腺癌肿瘤的类乳腺球体形成。

Comparison of mammosphere formation from breast cancer cell lines and primary breast tumors.

机构信息

1 Department of Thyroid and Breast Surgery, West China Hospital, Sichuan University, Chengdu 610041, China ; 2 Department of Breast Surgery, the Affiliated Hospital of Guiyang Medical College, Guiyang 550000, China ; 3 Laboratory of Stem Cell Biology, State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University, Chengdu 610041, China.

出版信息

J Thorac Dis. 2014 Jun;6(6):829-37. doi: 10.3978/j.issn.2072-1439.2014.03.38.

Abstract

BACKGROUND

Breast cancer stem cells (BCSCs) can be enriched by culturing of cells in non-adherent non-differentiating conditions. However, culturing mammospheres from primary breast tumors are costly and difficult to control. In order to overcome problems associated with using primary human tissues, continuous breast cancer cell lines have been developed from various sources.

METHODS

In this study, a luminal subtype breast cancer cell line MCF-7 and a basal subtype cell line MDA-MB-231 were chosen. We explored the optimal culturing system for BCSCs from the two cell lines and primary breast tumors. Then, mammosphere formation efficiency (MFE), CD44(+)/CD24(-/low)ESA(+)Lin(-) cell proportion in mammospheres, and tumorigenecity of mammospheres generated from the two breast cancer cell lines and primary breast tumors were compared.

RESULTS

Enzymatic digestion of 60 mins and the addition of B27 to the culture medium were optimal for mammosphere culturing. Mammospheres could be formed in all the three cells, in which MCF-7 had the highest MFE. After 3 weeks culture, CD44(+)/CD24(-/low)ESA(+)Lin(-) cell proportion in mammospheres from MCF-7, MDA-MB-231 cells and primary breast tumors was 95.0%±2.5%, 82%±22% and 21.5%±1.0%, respectively. A total of 1,000 cells from MCF-7, MDA-MB-231 mammospheres but not primary mammospheres were tumorigenic.

CONCLUSIONS

This study validates the use of breast cancer cell lines as models to elucidate the nature of BCSCs.

摘要

背景

乳腺癌干细胞(BCSCs)可通过在非贴壁非分化条件下培养细胞来富集。然而,从原发性乳腺癌培养类乳腺球体既昂贵又难以控制。为了克服使用原发性人组织相关的问题,已经从各种来源开发出了连续的乳腺癌细胞系。

方法

在这项研究中,选择了腔型乳腺癌细胞系 MCF-7 和基底型细胞系 MDA-MB-231。我们探索了这两种细胞系和原发性乳腺癌的最佳 BCSC 培养系统。然后,比较了从两种乳腺癌细胞系和原发性乳腺癌生成的类乳腺球体的形成效率(MFE)、类乳腺球体中 CD44(+)/CD24(-/低)ESA(+)Lin(-)细胞的比例以及类乳腺球体的致瘤性。

结果

60 分钟的酶消化和在培养基中添加 B27 是类乳腺球体培养的最佳条件。三种细胞均可以形成类乳腺球体,其中 MCF-7 的 MFE 最高。经过 3 周培养,MCF-7、MDA-MB-231 细胞和原发性乳腺癌来源的类乳腺球体中 CD44(+)/CD24(-/低)ESA(+)Lin(-)细胞的比例分别为 95.0%±2.5%、82%±22%和 21.5%±1.0%。只有 MCF-7 和 MDA-MB-231 的类乳腺球体中的 1000 个细胞而不是原发性类乳腺球体具有致瘤性。

结论

这项研究验证了使用乳腺癌细胞系作为模型来阐明 BCSC 的性质。

相似文献

引用本文的文献

7
Advances and Challenges in Cancer Stem Cells for Onco-Therapeutics.癌症干细胞在肿瘤治疗中的进展与挑战
Stem Cells Int. 2023 Dec 6;2023:8722803. doi: 10.1155/2023/8722803. eCollection 2023.

本文引用的文献

2
The increasing complexity of the cancer stem cell paradigm.癌症干细胞模式日益复杂。
Science. 2009 Jun 26;324(5935):1670-3. doi: 10.1126/science.1171837.
4
Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy.致瘤性乳腺癌细胞对化疗的内在抗性。
J Natl Cancer Inst. 2008 May 7;100(9):672-9. doi: 10.1093/jnci/djn123. Epub 2008 Apr 29.
9
Identification and expansion of human colon-cancer-initiating cells.人结肠癌起始细胞的鉴定与扩增。
Nature. 2007 Jan 4;445(7123):111-5. doi: 10.1038/nature05384. Epub 2006 Nov 19.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验